“Oncogenic Shock”: Explaining Oncogene Addiction through Differential Signal Attenuation
- 15 July 2006
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 12 (14) , 4392s-4395s
- https://doi.org/10.1158/1078-0432.ccr-06-0096
Abstract
“Oncogene addiction” describes the curious acquired dependence of tumor cells on an activated oncogene for their survival and/or proliferation, a phenomenon that has important implications for the success of targeted cancer therapies. However, the mechanisms explaining oncogene addiction remain elusive. We propose that “addiction” may be an illusion generated as a consequence of differential attenuation rates of prosurvival and proapoptotic signals emanating from an oncoprotein acutely following its inactivation. According to this model, which we call “oncogenic shock,” prosurvival signals dissipate quickly on oncoprotein inactivation whereas proapoptotic signals linger sufficiently long to commit the cell to an apoptotic death. This mechanism may contribute to the rapid and dramatic clinical responses observed in some cancer patients treated with selective tyrosine kinase inhibitors and could yield additional drug targets that determine the balance of signaling outputs from activated oncoproteins.Keywords
This publication has 14 references indexed in Scilit:
- The Concept of Synthetic Lethality in the Context of Anticancer TherapyNature Reviews Cancer, 2005
- Oncogene addiction: Sometimes a temporary slaveryCancer Cell, 2004
- Oncogene addictionSometimes a temporary slaveryCancer Cell, 2004
- Role of the p38 Mitogen-activated Protein Kinase Pathway in the Generation of the Effects of Imatinib Mesylate (STI571) in BCR-ABL-expressing CellsJournal of Biological Chemistry, 2004
- The Pro-apoptotic Ras Effector Nore1 May Serve as a Ras-regulated Tumor Suppressor in the LungJournal of Biological Chemistry, 2003
- Hyperosmolarity and CD95L trigger CD95/EGFR association and tyrosine phosphorylation of CD95 as prerequisites for CD95 membrane trafficking and DISC formationThe FASEB Journal, 2003
- Addiction to Oncogenes--the Achilles Heal of CancerScience, 2002
- A Novel MAPK Phosphatase MKP-7 Acts Preferentially on JNK/SAPK and p38α and β MAPKsJournal of Biological Chemistry, 2001
- Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markersCell Death & Differentiation, 1998
- Opposing Effects of ERK and JNK-p38 MAP Kinases on ApoptosisScience, 1995